Bilateral retinoblastoma: Long-term follow-up results from a single institution |
Choi, Sang Yul
(Department of Ophthalmology, Korea Cancer Center Hospital)
Kim, Dong Hwan (Department of Pediatrics, Korea Cancer Center Hospital) Lee, Kang Min (Department of Pediatrics, Korea Cancer Center Hospital) Lee, Hyun Jae (Department of Pediatrics, Korea Cancer Center Hospital) Kim, Mi-Sook (Department of Radiation Oncology, Korea Cancer Center Hospital) Lee, Tai-Won (Department of Ophthalmology, Korea Cancer Center Hospital) Choi, Sang Wook (Department of Pediatrics, Korea Cancer Center Hospital) Kim, Dong Ho (Department of Pediatrics, Korea Cancer Center Hospital) Park, Kyung Duk (Department of Pediatrics, Korea Cancer Center Hospital) Lee, Jun Ah (Department of Pediatrics, Korea Cancer Center Hospital) |
1 | Reese AB, Ellsworth RM. Management of retinoblastoma. Ann N Y Acad Sci 1964;114:958-62 DOI PUBMED ScienceOn |
2 | Ferris FL 3rd, Chew EY. A new era for the treatment of retinoblastoma. Arch Ophthalmol 1996;114:1412 DOI PUBMED ScienceOn |
3 | Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001;1:157-62 DOI PUBMED ScienceOn |
4 | Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al. Chemoreduction plus focal therapy for retinoblastoma: Factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 2002;133:657-64 DOI ScienceOn |
5 | Hall LS, Ceisler E, Abramson DH. Visual outcomes in children with bilateral retinoblastoma. J AAPOS 1999;3:138-42 DOI ScienceOn |
6 | Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist 2007;12:1237-46 DOI PUBMED |
7 | Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 2004;138:329-37 DOI ScienceOn |
8 | Scott IU, Murray TG, Feuer WJ, Van Quill K, Markoe AM, Ling S, et al. External beam radiotherapy in retinoblastoma: Tumor control and comparison of 2 techniques. Arch Ophthalmol 1999;117:766-70 DOI PUBMED ScienceOn |
9 | De Sutter E, Hoepping W, Zeller G. Comparison between different retinoblastoma classifications. Bull Soc Belge Ophtalmol 1993;248:19-22 PUBMED ScienceOn |
10 | Ellsworth RM. Retinoblastoma. Mod Probl Ophthalmol 1977; 18:94-100 PUBMED ScienceOn |
11 | Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 2005;23:2272-9 DOI ScienceOn |
12 | Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the weisenfeld lecture. Invest Ophthalmol Vis Sci 2005;46:2683-91 DOI ScienceOn |
13 | Hernandez JC, Brady LW, Shields JA, Shields CL, DePotter P, Karlsson UL, et al. External beam radiation for retinoblastoma: Results, patterns of failure, and a proposal for treatment guidelines. Int J Radiat Oncol Biol Phys 1996;35:125-32 DOI ScienceOn |
14 | Berman EL, Donaldson CE, Giblin M, Martin FJ. Outcomes in retinoblastoma, 1974-2005: the children's hospital, westmead. Clin Experiment Ophthalmol 2007;35:5-12 DOI ScienceOn |
15 | Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, et al. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol 2003;121:979-84 DOI ScienceOn |
16 | Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, et al. Retinoblastoma: one world, one vision. Pediatrics 2008;122:e763-70 DOI PUBMED ScienceOn |
17 | Song JS, Lee JK, Lee TW. Treatment and prognosis of retinoblastoma: clinicopathologic analysis of 101 cases. J Korean Opthamol Soc 1998;39:2293-405 |
18 | Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA. Practical approach to management of retinoblastoma. Arch Ophthalmol 2004;122:729-35 DOI ScienceOn |
19 | Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: A possible age effect on radiation-related risk. Ophthalmology 1998;105: discussion 579-80 DOI ScienceOn |
20 | Kliegman. Textbook of Pediatrics.18th ed. Philadelphia: Saunders Co, 2007:50-1 |
21 | Gombos DS, Kelly A, Coen PG, Kingston JE, Hungerford JL. Retinoblastoma treated with primary chemotherapy alone: The significance of tumour size, location, and age. Br J Ophthalmol 2002;86:80-3 DOI ScienceOn |
22 | Chung SE, Sa HS, Koo HH, Yoo KH, Sung KW, Ham DI. Clinical manifestations and treatment of retinoblastoma in Korea. Br J Ophthamol 2008;92:1180-4 DOI ScienceOn |
23 | Nahum MP, Gdal-On M, Kuten A, Herzl G, Horovitz Y, Weyl Ben Arush M. Long-term follow-up of children with retinoblastoma. Pediatr Hematol Oncol 2001;18:173-9 DOI ScienceOn |
24 | Gunduz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 1998;116:1613-7 DOI PUBMED |
25 | Abramson DH, Beaverson KL, Chang ST, Dunkel IJ, McCormick B. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316-23 DOI ScienceOn |